[1] |
Liu G, Pei F, Yang F, et al. Role of autophagy and apoptosis in non-small-cell lung cancer [J]. Int J Mol Sci, 2017, 18(2). pii: E367.
|
[2] |
范涛,耿庆,汪巍, 等. 自噬及其在肺部疾病中作用研究进展 [J]. 现代生物医学进展, 2017, 3(17): 567-571.
|
[3] |
Anding AL, Baehrecke EH. Cleaning house: selective autophagy of organelles [J]. Dev Cell, 2017, 41(1): 10-22.
|
[4] |
Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy [J]. Cell Mol Life Sci, 2016, 73(4): 775-795.
|
[5] |
Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy [J]. Nature, 2015, 524(7565): 309-314.
|
[6] |
Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer [J]. Genes Dev, 2016, 30(17): 1913-1930.
|
[7] |
Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors [J]. Cancer Res, 2005, 65(8): 3336-3346.
|
[8] |
Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy [J]. Science, 2011, 331(6016): 456-461.
|
[9] |
Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling [J]. Cell, 2008, 134(3): 451-460.
|
[10] |
Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues [J]. Cell, 2011, 147(4): 728-741.
|
[11] |
Liu J, Xia H, Kim M, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13 [J]. Cell, 2011, 147(1): 223-234.
|
[12] |
White E. Deconvoluting the context-dependent role for autophagy in cancer [J]. Nat Rev Cancer, 2012, 12(6): 401-410.
|
[13] |
Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor [J]. FEBS J, 2015, 282(24): 4672-4678.
|
[14] |
Umemura A, He F, Taniguchi K, et al. p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells [J]. Cancer Cell, 2016, 29(6): 935-948.
|
[15] |
Karantza-Wadsworth V, Patel S, Kravchuk O, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis [J]. Genes Dev, 2007, 21(13): 1621-1635.
|
[16] |
Guo JY, Karsli-Uzunbas G, Mathew R, et al. Autophagy suppresses progression of Kras-induced lung tumors to oncocytomas and maintains lipid homeostasis [J]. Genes Dev, 2013, 27(13): 1447-1461.
|
[17] |
Guo JY, Teng X, Laddha SV, et al. Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells [J]. Genes Dev, 2016, 30(15): 1704-1717.
|
[18] |
Sharifi MN, Mowers EE, Drake LE, et al. Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of paxillin with LC3 [J]. Cell Rep, 2016, 15(8): 1660-1672.
|
[19] |
Miyake N, Chikumi H, Takata M, et al. Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells [J]. Oncol Rep, 2012, 28(3): 848-854.
|
[20] |
Kim KW, Moretti L, Mitchell LR, et al. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model [J]. Clin Cancer Res, 2009, 15(19): 6096-6105.
|
[21] |
Gorzalczany Y, Gilad Y, Amihai D, et al. Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: a beneficial strategy to combat non-small cell lung cancer [J]. Cancer Lett, 2011, 310(2): 207-215.
|
[22] |
Lazarus MB, Shokat KM. Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1 [J]. Bioorg Med Chem, 2015, 23(17): 5483-5488.
|
[23] |
Ronan B, Flamand O, Vescovi L, et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy [J]. Nat Chem Biol, 2014, 10(12): 1013-1019.
|
[24] |
Akin D, Wang SK, Habibzadegah-Tari P, et al. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors [J]. Autophagy, 2014, 10(11): 2021-2035.
|
[25] |
Rangwala R, Chang YC, Hu J, et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma [J]. Autophagy, 2014, 10(8): 1391-1402.
|